vs
Side-by-side financial comparison of Ameris Bancorp (ABCB) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
Ameris Bancorp is the larger business by last-quarter revenue ($314.4M vs $208.9M, roughly 1.5× iRhythm Holdings, Inc.). Ameris Bancorp runs the higher net margin — 35.1% vs 2.7%, a 32.5% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 10.0%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 2.3%).
Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
ABCB vs IRTC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $314.4M | $208.9M |
| Net Profit | $110.5M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | — | 1.1% |
| Net Margin | 35.1% | 2.7% |
| Revenue YoY | 10.0% | 27.1% |
| Net Profit YoY | 2.0% | 518.5% |
| EPS (diluted) | $1.63 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $314.4M | — | ||
| Q4 25 | $307.1M | $208.9M | ||
| Q3 25 | $314.2M | $192.9M | ||
| Q2 25 | $300.7M | $186.7M | ||
| Q1 25 | $285.9M | $158.7M | ||
| Q4 24 | $290.8M | $164.3M | ||
| Q3 24 | $283.8M | $147.5M | ||
| Q2 24 | $300.6M | $148.0M |
| Q1 26 | $110.5M | — | ||
| Q4 25 | $108.4M | $5.6M | ||
| Q3 25 | $106.0M | $-5.2M | ||
| Q2 25 | $109.8M | $-14.2M | ||
| Q1 25 | $87.9M | $-30.7M | ||
| Q4 24 | $94.4M | $-1.3M | ||
| Q3 24 | $99.2M | $-46.2M | ||
| Q2 24 | $90.8M | $-20.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% |
| Q1 26 | — | — | ||
| Q4 25 | 45.9% | 1.1% | ||
| Q3 25 | 43.6% | -4.4% | ||
| Q2 25 | 47.4% | -10.0% | ||
| Q1 25 | 39.5% | -20.5% | ||
| Q4 24 | 43.3% | -2.5% | ||
| Q3 24 | 44.4% | -34.1% | ||
| Q2 24 | 42.1% | -15.5% |
| Q1 26 | 35.1% | — | ||
| Q4 25 | 44.2% | 2.7% | ||
| Q3 25 | 33.7% | -2.7% | ||
| Q2 25 | 36.5% | -7.6% | ||
| Q1 25 | 30.8% | -19.3% | ||
| Q4 24 | 42.5% | -0.8% | ||
| Q3 24 | 35.0% | -31.3% | ||
| Q2 24 | 30.2% | -13.6% |
| Q1 26 | $1.63 | — | ||
| Q4 25 | $1.59 | $0.18 | ||
| Q3 25 | $1.54 | $-0.16 | ||
| Q2 25 | $1.60 | $-0.44 | ||
| Q1 25 | $1.27 | $-0.97 | ||
| Q4 24 | $1.35 | $-0.03 | ||
| Q3 24 | $1.44 | $-1.48 | ||
| Q2 24 | $1.32 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.1B | $152.7M |
| Total Assets | $28.1B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $583.8M | ||
| Q3 25 | — | $565.2M | ||
| Q2 25 | — | $545.5M | ||
| Q1 25 | — | $520.6M | ||
| Q4 24 | — | $535.6M | ||
| Q3 24 | — | $522.0M | ||
| Q2 24 | — | $561.5M |
| Q1 26 | $4.1B | — | ||
| Q4 25 | $4.1B | $152.7M | ||
| Q3 25 | $4.0B | $121.9M | ||
| Q2 25 | $3.9B | $103.7M | ||
| Q1 25 | $3.8B | $86.7M | ||
| Q4 24 | $3.8B | $90.9M | ||
| Q3 24 | $3.7B | $71.8M | ||
| Q2 24 | $3.6B | $99.2M |
| Q1 26 | $28.1B | — | ||
| Q4 25 | $27.5B | $1.0B | ||
| Q3 25 | $27.1B | $995.2M | ||
| Q2 25 | $26.7B | $964.0M | ||
| Q1 25 | $26.5B | $926.1M | ||
| Q4 24 | $26.3B | $931.4M | ||
| Q3 24 | $26.4B | $909.7M | ||
| Q2 24 | $26.5B | $919.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $390.2M | $26.2M | ||
| Q3 25 | $104.9M | $34.9M | ||
| Q2 25 | $61.4M | $27.7M | ||
| Q1 25 | $116.9M | $-7.9M | ||
| Q4 24 | $154.2M | $19.2M | ||
| Q3 24 | $102.2M | $24.3M | ||
| Q2 24 | $-97.1M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | $369.6M | $14.5M | ||
| Q3 25 | $100.5M | $20.1M | ||
| Q2 25 | $53.7M | $17.3M | ||
| Q1 25 | $114.2M | $-17.3M | ||
| Q4 24 | $140.7M | $12.4M | ||
| Q3 24 | $99.8M | $15.5M | ||
| Q2 24 | $-100.3M | $3.4M |
| Q1 26 | — | — | ||
| Q4 25 | 120.4% | 6.9% | ||
| Q3 25 | 32.0% | 10.4% | ||
| Q2 25 | 17.9% | 9.3% | ||
| Q1 25 | 39.9% | -10.9% | ||
| Q4 24 | 48.4% | 7.5% | ||
| Q3 24 | 35.2% | 10.5% | ||
| Q2 24 | -33.4% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | 5.6% | ||
| Q3 25 | 1.4% | 7.7% | ||
| Q2 25 | 2.5% | 5.6% | ||
| Q1 25 | 0.9% | 5.9% | ||
| Q4 24 | 4.6% | 4.2% | ||
| Q3 24 | 0.8% | 6.0% | ||
| Q2 24 | 1.1% | 5.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.60× | 4.70× | ||
| Q3 25 | 0.99× | — | ||
| Q2 25 | 0.56× | — | ||
| Q1 25 | 1.33× | — | ||
| Q4 24 | 1.63× | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | -1.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCB
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |